№ lp_2_3_39691
File format: docx
Character count: 3611
File size: 219 KB
Clinical emergency management protocol and referral record outlining assessment, scoring, medication, specialist notification, transfer procedures, and documentation requirements for patients with suspected or confirmed malignant spinal cord compression within specified hospital networks.
Type of document:
Clinical guideline and referral form
Medical condition:
Malignant Spinal Cord Compression (MSCC)
Clinical status:
Oncological emergency
Institutions mentioned:
Southampton, Poole, Bath, SUHT
Responsible teams:
Acute Oncology Team (AOT); Clinical Oncology; Neurosurgery; Hospital Palliative Care Team (HPCT)
Required actions:
Urgent MRI spine; SINS score calculation; flat bed rest for SINS >6; dexamethasone administration; urgent referral to cancer centre
Medication specified:
Dexamethasone 16mg initial dose then 8mg b.d.; Lansoprazole 30mg o.d.; analgesia
Transfer requirement:
Urgent transfer for radiotherapy or neurosurgery
Contact method:
Bleep numbers and hospital telephone contacts
Documentation fields:
Referral times; MRI timing; confirmation of MSCC; signatures; transfer time; rehabilitation referral; audit entry
Target audience:
Referring doctors and Acute Oncology Team staff
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2020
Institution:
AmSECT
Document Type:
Clinical guideline
Target Population:
Patients with previously diagnosed risk or sudden onset of Malignant Hyperthermia
Purpose:
Guidance for detection, diagnosis, and management of Malignant Hyperthermia
Procedures Included:
Perfusion pump considerations, pharmacologic interventions, cooling strategies, laboratory testing
Approval:
Chief Medical Officer, Chief Nursing Executive
Effective Date:
2020
Version Number:
1.0
Review Period:
As changes occur or per institutional protocol
Year:
2006
Region / city:
United Kingdom
Topic:
Dermatology, Skin Cancer Treatment
Document Type:
Medical Treatment Guidelines
Institution:
National Institute for Health and Care Excellence (NICE)
Author:
Not specified
Target Audience:
Healthcare providers, General Practitioners (GPs), Dermatologists
Period of validity:
Not specified
Approval Date:
Not specified
Date of amendments:
Not specified
Year:
2014
Region / City:
Seattle
Topic:
Medical Genetics
Document Type:
Clinical Guidelines
Organization / Institution:
University of Washington
Author:
Schneiderbanger D, Johannsen S, Roewer N, Schuster F
Target Audience:
Healthcare professionals, Anesthesiologists
Period of Validity:
Not specified
Date of Approval:
2014
Date of Changes:
Not specified
Authors:
Joseph Westaby; Nesreen Magdy; Cyril Fisher; Mona El-Bahrawy
Institutions:
Department of Histopathology, Imperial College London, UK; Department of Histopathology, National Cancer Institute, Egypt; Sarcoma Unit, The Royal Marsden Hospital, UK; Faculty of Medicine, Alexandria University, Egypt
Corresponding author:
Dr Mona El-Bahrawy
Journal type:
Medical case report
Field:
Histopathology; Oncology; Gynaecological pathology
Keywords:
Perivascular Epithelioid Cell Neoplasms; PEComas; ovary; malignant; primary
Patient age:
54 years
Diagnosis:
Malignant primary ovarian PEComa
Clinical outcome:
Recurrence and death five months after surgery
Language:
English
Year:
2023
Region / City:
Srungavarapukota, Vizianagaram, Andhra Pradesh, India
Study Design:
Observational diagnostic study
Subjects:
Adult buffaloes aged 5–6 years
Diseases Investigated:
Border Disease Virus, Malignant Catarrhal Fever, Infectious Bovine Rhinotracheitis, Bovine Viral Diarrhea
Methodology:
Clinical evaluation, PCR, ELISA, sequencing, phylogenetic analysis
Results:
Co-infection with OvHV-2 and Border Disease Virus detected
Key Findings:
Sheep acted as primary reservoir, interspecies transmission risk highlighted
Target Audience:
Veterinary researchers and animal health professionals
Sample Collection Period:
November 2023
Laboratory Tests:
PCR for OvHV-2, Pestivirus, and IBR; ELISA for BVD
Document type:
Conference abstract and author biography
Presentation type:
Oral presentation
Research field:
Oncology
Topic:
XPO1 inhibition in solid malignant tumors
Author:
Chuanxi Lai
Affiliation:
Zhejiang University, School of Medicine
Academic status:
PhD candidate
Degree:
Bachelor of Medicine (2021)
Country:
China
Contact email:
[email protected]
Phone number:
86-18868117165
Journal mentioned:
Clinical and Translational Medicine
Keywords:
Exportin-1, XPO1, SINE inhibitors, selinexor, eltanexor, solid tumors, clinical trials, drug resistance
Year:
2018
Region / City:
Global
Topic:
Cancer Staging
Document Type:
Medical Classification
Organization / Institution:
UICC
Author:
Brierley JD, Gospodarowicz MK, Wittekind C
Target Audience:
Healthcare professionals, oncologists, pathologists
Period of Validity:
Ongoing
Date of Approval:
2017
Date of Changes:
Not specified
Year:
2020
Region / city:
UK
Subject:
Veterinary Medicine, Disease Outbreaks
Document Type:
Research Article
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Veterinary professionals, researchers
Period of validity:
Not applicable
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2026
Region / city:
Lanzhou, China
Field:
Oncology, Gastric Cancer
Document Type:
Research Article
Institution:
Gansu University of Chinese Medicine, Gansu Provincial Hospital
Author:
Xiao Dong, Yan Zhang, Na Liu, Jinrui Geng, Yu Li, Yonghong Li
Target Audience:
Researchers, Oncologists, Medical Professionals
Period of Study:
N/A
Approval Date:
N/A
Modification Date:
N/A
Keywords:
BMP8A, gastric cancer, malignant progression, MMP2, mechanism
Context:
A research article detailing the role of BMP8A in promoting gastric cancer progression via MMP2 regulation.
Year:
2026
Location:
United States
Subject:
Immunology, Monoclonal Antibodies, Mast Cell Biology
Document Type:
Research Supplement / Methods Section
Institution:
Kolltan Pharmaceuticals
Authors:
London et al.
Target Audience:
Scientific researchers in immunology and pharmacology
Experimental Period:
2026
Cell Types:
Human CD34+ progenitor cells, PBMCs, mast cells
Key Techniques:
Flow cytometry, antibody assays, cell differentiation, KIT phosphorylation
Reagents:
KTN0158, KTN0062C, KTN0209, KTN0235, Imatinib, Nilotinib, IL-3, IL-6, SCF, LDL
Year:
2021
Protocol Posting Date:
June 2021
Version:
4.1.0.0
Field:
Pathology
Medical Specialty:
Oncologic Pathology
Topic:
Pathologic evaluation of retroperitoneal lymphadenectomy specimens in testicular tumors
Document Type:
Clinical pathology reporting protocol and case summary template
Procedure:
Lymphadenectomy including retroperitoneal lymphadenectomy
Tumor Types Covered:
Germ cell tumors and sex cord-stromal tumors of the testis
Exclusions:
Radical orchiectomy, paratesticular malignancies, extragonadal germ cell tumors, lymphoma, sarcoma
Standard Referenced:
AJCC-UICC 8th Edition staging system
Organization:
College of American Pathologists
Committees:
CAP Cancer Committee; CAP Pathology Electronic Reporting Committee
Primary Authors:
Satish K. Tickoo; Gladell P. Paner; Ming Zhou
Additional Authors:
Lara R. Harik; Robert Allan; Mahul B. Amin; Sam S. Chang; Peter A. Humphrey; James M. McKiernan; Jason Pettus; Victor E. Reuter; John R. Srigley; Thomas M. Ulbright
Intended Users:
Pathologists reporting lymphadenectomy specimens in patients with testicular tumors
Data Structure:
Core, conditional, and non-core data elements for pathology reporting
Clinical Context:
Assessment of lymph node involvement and metastatic tumor characteristics in testicular cancer
Staging System:
Pathologic N classification (pN) according to AJCC 8th Edition
Organization:
MedWaves, Inc.
Headquarters:
San Diego, California, United States
Medical Field:
Neurosurgery
Topic:
Microwave ablation treatment for recurrent brain tumor
Type of Document:
Medical case report and product information statement
Medical Technology:
MedWaves AveCure® Microwave Ablation System
Location of Clinical Use:
Guadalajara, Mexico
Lead Physician:
Doctor Santana
Institution:
Major hospital in Guadalajara, Mexico
Condition Treated:
Recurrent malignant meningioma
Prior Treatments:
Five microsurgeries and full radiation therapy regimen
Procedure Type:
Microwave ablation used as an adjuvant tool in neuromicrosurgery
Patient Outcome Indicator:
Karnofsky Performance Score 90 at discharge
Imaging Method:
Magnetic resonance imaging (MRI)
Hospital Discharge:
8 days after microwave ablation procedure
Regulatory Status:
FDA 510(K), CE Mark, COFEPRIS registered
Manufacturer:
MedWaves, Inc.
Intended Medical Use:
Percutaneous, laparoscopic, and intraoperative coagulation-ablation of soft tissue
Contraindicated Use:
Cardiac procedures
Contact Information:
[email protected]
Note:
, Mobile 760-807-1000
Website:
www.medwaves.com
Year:
2017–2022
Region / City:
Kota Kinabalu, Sabah, Malaysia
Topic:
Neurology, Stroke, Neurosurgery
Document Type:
Retrospective observational cohort study
Institution:
Two tertiary referral centers
Authors:
Not specified
Target Audience:
Medical professionals, neurosurgeons
Patient Population:
Adult MMCAI patients undergoing decompressive craniectomy
Methodology:
CT imaging analysis, volumetric thalamic assessment, multivariable regression
Outcome Measures:
Mortality, NIHSS, mRS, BI, DRS, FOUR score, postoperative complications, hospital stay
Key Findings:
Ipsilateral thalamic volume reduction >14% associated with increased 90-day mortality and worse functional outcomes
Year:
2024
Region / City:
Not specified
Topic:
Neurofibromatosis type 1, Plexiform neurofibromas, Malignant peripheral nerve sheath tumor
Document Type:
Research article
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Researchers, medical professionals
Period of Action:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2021
Region / City:
Not specified
Subject:
Pathology of testicular germ cell and sex cord-stromal tumors
Document Type:
Clinical protocol
Institution / Organization:
College of American Pathologists (CAP)
Authors:
Satish K. Tickoo, Gladell P. Paner, Ming Zhou, Lara R. Harik, Robert Allan, Mahul B. Amin, Sam S. Chang, Peter A. Humphrey, James M. McKiernan, Jason Pettus, Victor E. Reuter, John R. Srigley, Thomas M. Ulbright
Target Audience:
Pathologists and clinical laboratories
Version:
4.1.0.1
Date of Publication:
November 2021
Procedures Covered:
Retroperitoneal lymphadenectomy
Tumor Types Covered:
Germ cell tumors, sex cord-stromal tumors
Excluded Procedures:
Radical orchiectomy, paratesticular malignancies, non-testis germ cell tumors, lymphoma, sarcoma
Reporting Standards:
AJCC-UICC 8th edition
Data Elements:
Core and non-core for electronic Cancer Checklists
Clinical Use:
Recommended but not required for accreditation
Year:
2021
Region / City:
Ottawa, IL
Theme:
Pipe Rehabilitation, Sealing Gaskets, CIPP Liners
Document Type:
Technical Specification
Organization / Institution:
LMK Technologies
Author:
LMK Technologies
Target Audience:
Professionals in pipe rehabilitation and CIPP liner installation
Period of Validity:
Not specified
Approval Date:
August 25, 2021
Date of Revision:
August 25, 2021
Year:
2016
Region / city:
Geneva, CH
Theme:
Biotechnology, Genomic Information Processing, Data Compression
Document Type:
Call for Proposals
Organization:
ISO/IEC JTC 1/SC 29/WG 11, ISO/TC 276/WG 5
Author:
ISO/IEC JTC 1/SC 29/WG 11, ISO/TC 276/WG 5
Target Audience:
Scientific and technical communities in biotechnology, bioinformatics, and data compression
Effective Period:
N/A
Approval Date:
June 2016
Revision Date:
N/A
Year:
2025
Region / City:
UK
Topic:
Gas transmission, biomethane, National Transmission System
Document Type:
Report
Organization / Institution:
Joint Office of Gas Transporters
Author:
Shiv Singh, Gavin Williams, Ed Allard
Target Audience:
Gas network operators, industry stakeholders
Period of Validity:
Not specified
Approval Date:
20 June 2025
Amendment Date:
17 July 2025
Year:
2024
Region / City:
UK
Topic:
Gas Distribution and Transmission Networks
Document Type:
Workgroup Report
Organization / Institution:
Gas Transporters
Author:
Shiv Singh, Gavin Williams, Ed Allard
Target Audience:
Gas Transporters, Network Operators, Industry Stakeholders
Effective Period:
June 2026
Approval Date:
07 February 2025
Modification Dates:
04 July 2024, 06 August 2024, 15 August 2024, 05 September 2024, 15 May 2025
Consultation Close-out Date:
20 June 2025
Final Modification Report Date:
20 June 2025
Modification Panel Decision Date:
17 July 2025